NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,180
High1,194.3
Low1,150.5
Prev. Close1,158.4
Avg. Traded Price1,163.7
Volume3,06,004
MARKET DEPTH
Total bid0.00
Total ask485.00
| Orders | Qty | Bid |
|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|
| 1158.4 | 9 | 485 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
HIGH/LOW
LOW/HIGH
₹1,150.60an hour ago
₹1,194.307 hours ago
Bandhan Small Cap Fund-Reg(G)
3Y Return+27.2%
NAV₹256.57
UTI Healthcare Fund-Reg(IDCW)
3Y Return+26.2%
NAV₹229.30
Motilal Oswal BSE Healthcare ETF
Motilal Oswal Nifty Smallcap 250 Index Fund-Reg(G)
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses. With a solid network of radio-pharmacies in the US, Jubilant’s Radiopharma business is engaged in manufacturing and supply of Radiopharmaceutical products and services. Its other businesses such as Allergy Immunotherapy, Contract Manufacturing of Sterile Injectables and Non-sterile products and Generics (Solid Dosage Formulations) caters to major regulated markets (USA, EU and other geographies) through five manufacturing facilities. The CRDMO segment (through Jubilant Biosys) provides collaborative research and partnership for Drug Discovery through two world class research centers in India. The company is also involved in the manufacturing of Active Pharmaceutical Products (API) through a US FDA approved facility in Nanjangud, Karnataka.
